PM
BIIB icon

Parametrica Management’s Biogen BIIB Stock Holding History

Parametrica Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-680
Closed -$236K – 80
2021
Q2 		$236K Sell
680
-6,672
-91% -$2.02M 0.17% 71
2021
Q1 		$2.03M Sell
7,352
-3,631
-33% -$979K 0.98% 29
2020
Q4 		$2.69M Buy
10,983
+9,295
+551% +$2.4M 1.66% 15
2020
Q3 		$479K Sell
1,688
-67
-4% -$18.7K 0.9% 34
2020
Q2 		$469K Buy
+1,755
New +$528K 0.52% 44
2018
Q1 		– Sell
-673
Closed -$214K – 242
2017
Q4 		$214K Buy
673
+26
+4% +$8.34K 0.14% 310
2017
Q3 		$203K Buy
+647
New +$192K 0.09% 322
2014
Q2 		– Sell
-714
Closed -$218K – 59
2014
Q1 		$218K Buy
+714
New +$227K 1.85% 32

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parametrica Management's BIIB Position: Q3 2021 in Review

Parametrica Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 680 shares — an estimated $236K sold.

Parametrica Management first reported a position in BIIB in Q1 2014 and held it in 8 quarters. The position peaked at $2.69M in Q4 2020. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Parametrica Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Parametrica Management sold 680 Biogen shares in Q3 2021, an estimated $236K.
  • Parametrica Management first reported a position in Biogen in Q1 2014 and held it in 8 quarters.
  • Parametrica Management's Biogen position peaked at $2.69M in Q4 2020.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Parametrica Management's 13F filing for Q3 2021, filed 12 Nov 2021.